BP Plc´s investors can add more claims to a multibillion-dollar lawsuit accusing the company of lying before and after the 2010 Gulf of Mexico oil spill, a U.S. judge ruled.
A prize-insurance company sued Lance Armstrong on Thursday in Texas state court in a bid to recover $12 million paid out to the former pro cyclist for three of his Tour de France wins.
Hedge fund manager David Einhorn sued Apple Inc. Thursday over a plan by the company to make it more difficult to issue preferred shares that pay a dividend—something Mr. Einhorn has urged the company do to return more of its cash pile to investors.
A sanitation official said Wednesday the idea is under discussion but it´s too soon to say what will get recommended in an upcoming report on increasing recycling rates.
Members of the punk group Pussy Riot sued Russia at the European Court of Human Rights, saying their conviction on charges related to a protest against President Vladimir Putin violated their rights to freedom of expression.
CVS Caremark Corp said on Wednesday it bought Drogaria Onofre, Brazil´s eighth-largest drugstore chain last week, marking the first time the drugstore and pharmacy services company has ventured outside the United States.
A bill that would allow public school teachers or administrators who successfully complete a basic police course academy for reserve deputies to bring loaded handguns to school passed a legislative committee Wednesday.
If it isn´t already daunting enough to pack for a trip to fashionable Paris, female visitors, beware: It´s illegal to wear pants.
Brazil´s copyright regulator will strip Apple Inc of the right to use its iPhone trademark in Latin America´s biggest market and granted the trademark to a local company that registered it first, a source familiar with the decision said on Tuesday.
Dell Inc. neared an agreement on Monday to sell itself to a group led by its founder and the investment firm Silver Lake for more than $23 billion, people briefed on the matter said, in what would be the biggest buyout since the financial crisis.
British drugmaker GSK, which paid $3bn last year to settle charges that it gave misleading information on its medicines, said it would publish more of its clinical research data.
voltar para o topo